Skip to content

The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs

Can the Choice of the Local Anesthetic Have an Impact on Ambulatory Surgery Perioperative Costs? Chloroprocaine for Popliteal Block in Outpatient Foot Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02406703
Enrollment
100
Registered
2015-04-02
Start date
2014-01-31
Completion date
2014-05-31
Last updated
2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of Anesthetic Choice on Costs

Keywords

local anesthesia, regional anesthetic

Brief summary

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet. Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

Interventions

DRUGMepivacaine

Sponsors

Ospedale Regionale Bellinzona e Valli
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction, screws and/or plaques removal)

Exclusion criteria

* known allergy to drugs used in the study; * coagulopathies, known neuropathy; * pregnancy; * chronic pain; * drug or alcohol abuse; * psychiatric disease or lack of competence affecting compliance and evidence of ongoing sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.

Design outcomes

Primary

MeasureTime frame
Cost minimization analysis6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026